Paladin Pharma is a specialty pharmaceutical company focused on bringing differentiated prescription products to the Canadian market through licensing, commercialization, and product partnerships. Its public materials highlight a portfolio spanning neurology, anti-infectives, transplantation, and rare or specialized therapies. The business has long operated as a commercial platform for specialty brands that need Canadian regulatory and market access support.